Journal of translational medicine
Narciclasine as a potential therapeutic agent to overcome EGFR-TKI resistance in non-small cell lung cancer.
Jee Young Sung, Ha-Eun Yoo, Soomi Kim, Suyeun Yu, Sang-Won Park, Ga-Eun Lim, Byung Il Lee, Kyungsil Yoon, Hyo Jung Kim, Sang-Ku Ye, Jaegal Shim, Yong-Nyun Kim
Published: 202510.1186/s12967-025-07368-4
No abstract available for this study.